Key result
Thrombolytic therapy offers mortality benefits in acute massive pulmonary embolism with hypotension and prevents clinical deterioration in submassive pulmonary embolism.
Why the study?
Does thrombolytic therapy in conjunction with anticoagulant therapy improve outcomes in patients with pulmonary embolism?
Population
Patients with pulmonary embolism, including acute massive pulmonary embolism with hypotension and submassive…
Design
Review
Authors
Loading...
Supports thrombolysis consideration in select PE; hypothesis-generating and requires prospective validation before practice change.
Does thrombolytic therapy in conjunction with anticoagulant therapy improve outcomes in patients with pulmonary embolism?
Thrombolytic therapy provides mortality benefits in massive pulmonary embolism and prevents clinical deterioration in submassive cases.
Lexin Wang (2005) conducted a review in Pulmonary embolism. Thrombolytic therapy was evaluated. Thrombolytic therapy offers mortality benefits in acute massive pulmonary embolism with hypotension and prevents clinical deterioration in submassive pulmonary embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: